Archives: Agenda

In this session, we’ll address five of the most common myths surrounding mobile visits, replacing assumptions with real-world data and operational insights:

• Consistent clinician assignments build trust and strengthen patient relationships
• Mobile visits can offer greater privacy and comfort than traditional sites
• Decentralized models can accommodate complex protocols without compromising quality
• Structured planning makes mobile visits logistically viable and scalable
• Bringing research directly into communities expands access and improves retention and inclusivity

• How sponsor and CRO priorities differ, and the importance of clearly defined roles in fostering effective site partnerships
• Key distinctions between site engagement and site management, and how responsibilities should be strategically allocated
• Opportunities for sponsors to strengthen site relationships through proactive engagement and thoughtful collaboration
• Best practices for leveraging CRO networks and KOL partnerships to support site success, particularly in later-phase trials

• Streamlining vendor management to reduce costs and timelines and to improve overall operational efficiency: Clear communication, defined roles and responsibilities and standardized documentation to enhance accessibility and collaboration
• Mitigating risks associated with compliance, quality, and data integrity and reducing the impact of delays in patient recruitment, data collection, and regulatory submissions on trial budgets and timelines
• Setting specific, measurable KPIs to evaluate vendor performance throughout the trial, focusing on metrics such as patient enrollment rates, data accuracy, and timeline adherence
• Leverage technology for real-time monitoring of trial progress and vendor performance, allowing prompt identification of issues
• Comprehensive evaluation of the closing out the trial process: Aligning goals, timelines and encouraging proactive management of timelines to identify potential bottlenecks early and involve vendors in the resolution process

• Voyage of Discovery: Why we crossed the ocean for our FIH Trial
• Speed Dating: Choosing partners for the clinical research dance
• Do You Feel a Draft?: Endless iterations of study-specific documents
• H-Wrecked: navigating unexpected reefs in the journey to study start-up
• Out of Site, Out of Mind

• Acknowledging the value that patients can bring to every stage of the drug development pathway
• Engaging patients and advocacy groups early on in the clinical trial design process
• How minimizing participant burden leads to on-time enrollment and completion
• Combining patient perspectives with those of healthcare professionals to create a holistic trial model
• Highlighting how to compensate patients

Moderator: Amanda Murphy, Senior Director, Data Intelligence & Solutions, GlobalData